BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34371012)

  • 21. A rapid and efficient newly established method to detect COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans.
    Yokoyama Y; Shimizu A; Okada E; Ishikawa O; Motegi S
    Biochem Biophys Res Commun; 2012 Aug; 425(2):353-6. PubMed ID: 22842571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the COL1A1-PDGFB fusion gene in a case of dermatofibrosarcoma protuberans with a fibrosarcoma component].
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Calabuig S; Botella R; Nagore E; Requena C; Guillén C; Cremades A; Pellín A; Llombart-Bosch A
    Actas Dermosifiliogr; 2006 Jun; 97(5):337-41. PubMed ID: 16956568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
    Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans.
    Takahira T; Oda Y; Tamiya S; Higaki K; Yamamoto H; Kobayashi C; Izumi T; Tateishi N; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2007 Jun; 20(6):668-75. PubMed ID: 17431412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
    Kesserwan C; Sokolic R; Cowen EW; Garabedian E; Heselmeyer-Haddad K; Lee CC; Pittaluga S; Ortiz C; Baird K; Lopez-Terrada D; Bridge J; Wayne AS; Candotti F
    J Allergy Clin Immunol; 2012 Mar; 129(3):762-769.e1. PubMed ID: 22153773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions.
    Lee PH; Huang SC; Wu PS; Tai HC; Lee CH; Lee JC; Kao YC; Tsai JW; Hsieh TH; Li CF; Li WS; Liu TT; Su YL; Yu SC; Huang HY
    Am J Surg Pathol; 2022 Jul; 46(7):942-955. PubMed ID: 35034038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP).
    Simon MP; Navarro M; Roux D; Pouysségur J
    Oncogene; 2001 May; 20(23):2965-75. PubMed ID: 11420709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma.
    Vanni R; Faa G; Dettori T; Melis GB; Dumanski JP; O'Brien KP
    Virchows Arch; 2000 Jul; 437(1):95-100. PubMed ID: 10963386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
    Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
    Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of COL1A1/PDGFB fusion transcripts in dermatofibroscoma protuberans by revers transcriptase-polymerase chain reaction using paraffin-embedded tissues].
    Yang JH; Hu WH; Li F; Lu TC; Li HA; Chang B; Zhang XB; Zhou XM; Dang HW
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):409-12. PubMed ID: 14633450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COL1A1-PDGFB Fusion Associated Fibrosarcoma of the Uterine Corpus: A Case Report and Literature Review.
    Panwar V; Liu Y; Gwin K; Chen H
    Int J Gynecol Pathol; 2023 Mar; 42(2):143-146. PubMed ID: 36729934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
    Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans.
    Saeki H; Tamada Y; Watanabe D; Akita Y; Matsumoto Y; Imai C; Kadono T; Maekawa T; Hattori N; Watanabe A; Torii H; Tamaki K
    Clin Exp Dermatol; 2006 May; 31(3):441-4. PubMed ID: 16681596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.
    O'Brien KP; Seroussi E; Dal Cin P; Sciot R; Mandahl N; Fletcher JA; Turc-Carel C; Dumanski JP
    Genes Chromosomes Cancer; 1998 Oct; 23(2):187-93. PubMed ID: 9739023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.
    Bianchini L; Maire G; Guillot B; Joujoux JM; Follana P; Simon MP; Coindre JM; Pedeutour F
    Virchows Arch; 2008 Jun; 452(6):689-96. PubMed ID: 18253748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
    Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
    Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.